Skip to Primary Navigation

Indian pharma faces challenge from Trump tariffs and US regulators

Indian pharmacy
4 out of 10 prescriptions filled in the US in 2022 were made in India. Photo: Eric Lafforgue/Getty Images

The US is the third largest importer of drugs made in India. But President Trump’s tariffs plan could derail bilateral trade ties.

For decades, India’s export of generic drugs to the US has presented a perfect example of a mutually beneficial trade relationship between the two countries.

The US remains the third largest importer of drugs made in India. The bilateral trade in pharmaceuticals between the two countries is worth around $12.7recent